Stopped: Disparate corneal thickness readings from two measurement techniques employed.
Patients in for treatment of benign intracranial hypertension will undergo two tests that are not routinely performed for these patients: central corneal thickness and axial length of the eye. The data obtained from these measurements will be assessed to see if the correlate with aspects of vision loss including visual acuity, visual field status, optical coherence tomography (OCT) results, and fundus photographs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Axial Length
Timeframe: Single measurement during ultrasound procedure on the day of enrollment in the study on average of 5 minutes.